Filter
3997
Filtered Results: 3997
Text search:
drug
distribution
Featured
Recommendations
326
New Publications
1153
Language
Document type
No document type
2482
Studies & Reports
647
Guidelines
468
Manuals
159
Strategic & Response Plan
127
Fact sheets
42
Training Material
39
Situation Updates
21
Infographics
7
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
127
Uganda
104
Ethiopia
99
Nigeria
96
South Africa
84
Sierra Leone
77
Tanzania
74
Liberia
74
Nepal
73
Western and Central Europe
73
Malawi
71
Latin America and the Carribbean
61
Zambia
61
Myanmar / Burma
60
Ghana
58
Bangladesh
55
Rwanda
54
Africa
47
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Lesotho
30
Cambodia
30
South–East Asia Region
28
Asia
26
Senegal
24
Botswana
23
Congo, Democratic Republic of
20
Russia
20
Indonesia
20
Burkina Faso
19
Mozambique
19
Colombia
16
East and Southern Africa
15
Syria
14
Haiti
14
Eswatini/ Swaziland
13
Venezuela
12
Albania
11
Paraguay
11
South Sudan
11
Thailand
10
Cameroon
10
USA
10
West and Central Africa
10
Benin
9
Middle East and North Africa
9
Brazil
9
Tajikistan
8
Peru
8
Guinea
8
Germany
8
Eastern Europe and Central Asia
8
Pakistan
8
Argentina
7
Sudan
7
Georgia
7
Vietnam
6
Moldova
6
North Macedonia
5
China
5
Laos
5
Afghanistan
5
Bolivia
5
Iraq
5
El Salvador
4
Chile
4
Armenia
4
Spain
4
Sri Lanka
4
Timor Leste/ East Timor
3
Turkey
3
Morocco
3
Jordan
3
Western Pacific Region
3
North America
3
Lebanon
3
Papua New Guinea
3
Bhutan
3
Mexico
2
Iran
2
Fiji
2
Kyrgyzstan
2
Uzbekistan
2
Mongolia
2
Gabon
2
Uruguay
2
Tunisia
2
United Kingdom
2
Portugal
2
Yemen
2
Central African Republic
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Serbia
1
Kazakhstan
1
Canada
1
Estonia
1
Bulgaria
1
Hungary
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Mali
1
Angola
1
Chad
1
Somalia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1662
Clinical Guidelines
333
Public Health
206
Women & Child Health
138
Key Resources
113
Pharmacy & Technologies
56
Capacity Building
47
Annual Report MEDBOX
1
Toolboxes
HIV
436
Mental Health
345
TB
317
NTDs
214
AMR
189
COVID-19
156
Pharmacy
146
Rapid Response
69
Caregiver
64
Planetary Health
58
NCDs
58
Ebola & Marburg
50
Refugee
48
Disability
46
Conflict
44
Global Health Education
41
Health Financing Toolbox
34
Natural Hazards
20
Specific Hazards
15
Cholera
15
Polio
15
Zika
14
Malaria
10
Social Ethics
7
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to...
This standard Operating procedure (SOP) for JDWNRH is intended to describe and
address various important areas like admission procedure, on call process of the
doctors, interdepartmental consultation, patient discharge process and verity of
other areas which was so far solely based on verbal i...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
a selection of 150 commonly used species 2nd. ed.
For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable ...
The Open AIDS Journal, 2012, 6, 245-258
Making the Case for Alcohol as a Public Health Threat in the Region. The purpose of this document is to explain the need for making alcohol a top public health priority in the region and the need for national and regional action. Current evidence-based research shows that alcohol consumption and dri...
In an environment of stagnant donor funding and increasing private sector investment in low- and middle-income countries, actors in both the public and private sectors are increasingly interested in using blended finance approaches to catalyze new funding for global health and achieve health outcome...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
Climate change threatens to undermine the past 50 years of gains in public health. In response, theNational Health Service (NHS) in England has been working since 2008 to quantify and reduce its carbon footprint.
This Article presents the latest update to its greenhouse gas accounting, identifying ...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
